Cardiovascular, renal and metabolic diseases

This module describes the bidirectional relationship between renal function and cardiovascular disease, and the impact on patients with chronic kidney disease.

It includes information on the incidence and recommended management of: hypertension, coronary artery disease, arrythmias/atrial fibrillation, heart failure, and valvular heart disease.
Format

Self-Paced Online
Course

Author

Professor Debasish Banerjee

Duration

2 Hours

Audience

Nephrologists and Medical Professionals

About the course

This course has been developed for trainee nephrologists and others in the UK nephrology community. This module is part of the CKD eLearning course composed of multiple modules that have been developed to encompass key elements of the syllabus for the Speciality Training Curriculum for Renal Medicine, as developed by the Joint Royal Colleges of Physicians Training Board.

This eLearning course is a collaboration between the UK Kidney Association and Astellas to develop robust and engaging modular content that aims to deliver maximum educational benefit to trainee nephrologists and others in the UK nephrology community.

Advance your knowledge

Improve patient outcomes

Content overview

  • Impact of declining renal function on cardiovascular risk and mortality
  • Hypertension in patients with chronic kidney disease (CKD)
  • Arrythmias and atrial fibrillation in CKD
  • Heart failure in patients with CKD
  • Valvular hear disease in CKD

Professor Debasish Banerjee

Professor Banerjee is the chair of the UK Kidney Association Education & Training Committee. He is a clinical nephrologist managing CKD, dialysis and kidney transplant patients with much expertise in CKD patients with cardiovascular disease, hypertension, heart failure and diabetes. As a member of the European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacotherapy, and following his establishment of a unique kidney failure - heart failure clinic at St George’s, he has created international strategies for managing CKD patients with cardiovascular disease. As part of the Association of British Clinical Diabetologists (ABCD) Renal Association Clinical Study Group, he has assisted in the formulation of national guidelines for the management of CKD patients with the added complication of diabetes. Professor Banerjee also works as the steering committee member of the International Society of Nephrology, Cardio-Renal Group.